Terpin is an expectorant, used to loosen mucus in patients with bronchitis and related conditions. It is used as the hydrate (terpin·H2O). Chemically it is a monoterpene-derived hydrate used historically as an OTC expectorant and as a component in compound formulations; it is moderately soluble in aqueous alcohol and is formulated as syrups, elixirs, and tablet blends for oral administration. It is derived from sources such as turpentine, oregano, thyme, and eucalyptus. It has been characterized by IR, GC-MS, and HPLC fingerprinting to confirm identity and to control related terpene impurities. It was used in the United States in t + some more technical info and was listed in older pharmacopeial monographs where specifications included assay, moisture content, and limits for related substances. Current clinical use is limited compared with modern mucolytics but the compound remains of interest for formulation chemistry and historical reference.
Parent: Terpin/ Terpin Hydrate
Typical impurity and related compound profiles for commercial terpin hydrate preparations reflect the monoterpene origin and the hydrate state; specifications commonly used in quality control show assay of active material at or above 98% on a dry basis, moisture content consistent with the monohydrate form typically in the range 6 to 9% by weight, and individual related impurities present at trace to low-percent levels. Common related compounds detected by GC-MS include alpha-terpinene, gamma-terpinene, p-cymene, limonene, terpinen-4-ol, and alpha-terpineol; typical analytical ranges reported for these related substances are approximately 0.05 to 3.0% for individual constituents and a combined related-substance total usually controlled below 5.0%. Residual solvents are controlled to pharmacopoeial limits, and elemental impurities are monitored per ICH Q3D guidelines. Identification and quantitation are routinely done by GC with flame ionization detection or GC-MS, supported by HPLC profiling when needed.
Terpin is used as an expectorant to loosen and promote clearance of bronchial mucus in conditions such as bronchitis and other productive cough states; it has also been used historically in compound cough preparations and in formulation research.
Reported side effects include gastrointestinal upset such as nausea and vomiting, dizziness, mild headache, and hypersensitivity reactions including rash and urticaria in susceptible individuals; overdose can cause more pronounced CNS effects and requires clinical evaluation.
Terpin refers here to terpin hydrate, a hydrate form of a monoterpene-derived expectorant; the name denotes the chemical class (terpenes) and the hydrated state used pharmaceutically.
Terpin is thought to act as an expectorant by mildly irritating the gastric mucosa and stimulating vagal reflexes that increase bronchial secretions and ciliary activity, and by direct physicochemical effects on mucus viscosity, which together facilitate mucus loosening and expectoration.